New research indicates that people who discontinue popular slimming jabs like Mounjaro or Wegovy tend to recover shed pounds far faster than those who stop conventional lifestyle plans.
Research printed in a major medical journal demonstrates that while overweight individuals frequently drop a large proportion of their total mass while using the jabs, the weight returns at an average rate of nearly a kilo each month upon discontinuation.
"Users purchasing such treatments should be aware of the risk of quick weight regain when the medication ends," cautioned lead investigator Dr. Susan Jebb.
That rate of regain implies a return to original weight in about one and a half years.
Weighing Approaches
The research, which reviewed 37 of studies involving thousands of participants, compared the results of the injectable medications with older methods.
Researchers point out that people who lose weight through diet and exercise usually experience a slower creep back—perhaps 100 grams monthly—after stopping.
Understanding the Fast Rebound
Nutrition scientists believe the mode of action of the drugs is key to understanding the heightened regain.
GLP-1 drugs imitate a natural hormone called GLP-1, which moderates appetite.
"Long-term administration of GLP-1 levels several times higher than normal could lead to the system to produce less of its endogenous hormone, and could reduce sensitivity to its actions," said Dr. Adam Collins, a dietetics researcher.
"Stopping of this medication leads to hunger is unsuppressed, making excessive eating much more probable."
A Lifelong Issue?
Medical guidelines suggest the injections for people with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
Many experts contend that, considering the significant potential of relapse, the treatment is often long-term.
This perspective is echoed by drug manufacturers, who say that the findings "emphasize the long-term character of obesity," comparing it to managing diseases like high blood pressure.
Patient Testimonies
Individuals who have stopped the jabs explain a powerful resurgence of cravings.
"It felt as if a switch that goes on and I was suddenly ravenous," said one woman.
The struggle is worsened if users have not developed lasting dietary or behavioural modifications during therapy.
Widespread Use
Figures suggest that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial.
- Use is greater among females compared to men.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion access the medications through private healthcare rather than public health services.
In conclusion, experts emphasize that while GLP-1 drugs are effective tools for shedding pounds, they are not a standalone cure and maintained weight loss hinges on integrated lifestyle support.
